New Products

NEW YORK — Skin care brand CeraVe, developed by Valeant Pharmaceuticals North America, is expanding its portfolio with a line of sun care products slated to hit stores beginning this month.

The new CeraVe Sun Care line, developed with dermatologists, includes eight products for the face and body with various applications offering both broad spectrum SPF 30 and SPF 50 protection, and will be sold in the sun protection aisle in drug stores and mass market.

EDEN PRAIRIE, Minn. -- Strictly speaking, television is a pulsating blue light, which is why from the outside of a house, it makes it look as though the entire living room or bedroom is glowing blue while turned on. That's the basic principal behind a new device designed to ward off burglars.

FakeTV, manufactured by Hydreon Corp., uses LEDs to simulate the light produced by a television set, using a built-in computer to produce effects that emulate variations in light and color that come from scene changes, camera pans, fades, flicks and on-screen motion.

NEW YORK — South Beach Diet on Thursday revealed a new addition to its line of nutritious and convenient foods — creamy South Beach Diet Snack Smoothies.

BENTONVILLE, Ark. — Walmart and Sam's Club are introducing a new contact lens program for 2013, the retailers said Thursday.

The new program will allow customers to visit Walmart's or Sam's Club's website or call a toll-free number to place contact lens orders and have them delivered to their homes, with free shipping available for orders of more than $50. In addition, the two are offering low prices for certain Acuvue, Air Optix and Biofinity lenses, while Walmart is planning to launch its private-label Equate brand in February.

PARSIPPANY, N.J. — The Food and Drug Administration has approved a generic epilepsy drug made by Wockhardt, the company said.

Wockhardt, based in India, announced the approval of lamotrigine extended-release tablets in the 25-mg, 50-mg, 100-mg, 200-mg and 300-mg strengths.

The drug is a generic version of GlaxoSmithKline's Lamictal XR. The U.S. market for the drug is about $250 million, according to IMS Health.

NEW YORK — Demand among consumers for online services from drug companies to help manage chronic conditions is strong, according to a new study from healthcare market research firm Manhattan Research.

MCHENRY, Ill. — The Calma breastmilk feeding system from Medela, which helps emulate the breastfeeding experience for babies, is now available in major national retail stores, Medela announced Thursday. Calma is a research-based nipple used with a BPA-free breastmilk bottle, designed to help babies maintain their natural feeding behavior and transition from bottle back to breast with ease.

WAYNE, N.J. — The Food and Drug Administration has approved a new intrauterine device for preventing pregnancy made by Bayer HealthCare Pharmaceuticals, the drug maker said.

Bayer announced the approval of Skyla (levonorgestrel-releasing uterine system), which can prevent pregnancy for up to three years. The IUD contains 13.5 mg of levonorgestrel.

Nearly 50% of pregnancies in the United States are unintended, according to the National Center for Health Statistics.